Radius Health to Present at the Cowen 38th Annual Health Care Conference
March 06 2018 - 8:01AM
Radius Health, Inc. (Nasdaq:RDUS) announced today that Jesper
Høiland, President and CEO of the Company, will present a corporate
update at Cowen’s 38th Annual Health Care Conference on Monday,
March 12, 2018.
Information on the presentation is as follows:
Event:
Cowen 38th Annual Health Care Conference Date:
Monday,
March 12, 2018 Time:
3:30 p.m. EDT Location:
Dartmouth Room, 3rd Floor, Boston
Marriott Copley Place, Boston, MA
A live webcast of the presentation will be available by visiting
the Investors section of Radius' website at
http://ir.radiuspharm.com/events.cfm. A replay of the webcast will
be archived on Radius' website for 30 days following the
presentation.
About Radius Health
Radius is a science-driven fully integrated biopharmaceutical
company that is committed to developing and commercializing
innovative endocrine therapeutics in the areas of osteoporosis and
oncology. Radius' lead product, TYMLOS (abaloparatide) injection,
was approved by the U.S. Food and Drug Administration for the
treatment of postmenopausal women with osteoporosis at high risk
for fracture. Radius' Marketing Authorisation Application (MAA) for
abaloparatide-SC for the treatment of postmenopausal women with
osteoporosis is under regulatory review in Europe. The Radius
clinical pipeline includes an investigational abaloparatide patch
for potential use in osteoporosis; the investigational drug
elacestrant (RAD1901) for potential use in hormone-receptor
positive breast cancer; and the investigational drug RAD140, a
non-steroidal, selective androgen receptor modulator (SARM) under
investigation for potential use in hormone-receptor positive breast
cancer. For more information, please visit www.radiuspharm.com, and
follow us on Twitter and LinkedIn.
Investor Relations Contact:
Elhan Webb, CFA Email: ewebb@radiuspharm.com Phone:
617-551-4011
Radius Recycling (NASDAQ:RDUS)
Historical Stock Chart
From Aug 2024 to Sep 2024
Radius Recycling (NASDAQ:RDUS)
Historical Stock Chart
From Sep 2023 to Sep 2024